Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × Granulocyte Colony-Stimulating Factor × Clear all

NCT00862134 2013-01-10

Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Terminated

42 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung